furosemide has been researched along with Infant, Newborn, Diseases in 27 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an attempt to explore the possible role of prolactin (PRL) in the control of neonatal electrolyte homeostasis, this study has been carried out to compare plasma electrolyte concentrations, urine volume and urinary electrolyte excretion as well as plasma PRL levels in healthy full-term neonates with idiopathic edema prior to and after furosemide treatment." | 7.67 | Plasma prolactin levels in full-term newborn infants with idiopathic edema: response to furosemide. ( Bódis, J; Csaba, IF; Ertl, T; Sulyok, E, 1986) |
| "In an attempt to explore the possible role of prolactin (PRL) in the control of neonatal electrolyte homeostasis, this study has been carried out to compare plasma electrolyte concentrations, urine volume and urinary electrolyte excretion as well as plasma PRL levels in healthy full-term neonates with idiopathic edema prior to and after furosemide treatment." | 3.67 | Plasma prolactin levels in full-term newborn infants with idiopathic edema: response to furosemide. ( Bódis, J; Csaba, IF; Ertl, T; Sulyok, E, 1986) |
| "Subcutaneous fat necrosis of the newborn is an uncommon, self-limiting panniculitis that usually occurs in full-term infants as a consequence of perinatal asphyxia." | 1.33 | Subcutaneous fat necrosis of the newborn: be aware of hypercalcaemia. ( Borgia, F; Cacace, C; Cannavo, SP; De Pasquale, L; Guarneri, C; Meo, P, 2006) |
| "Symptomatic patent ductus arteriosus (sPDA) may occur in up to 50% of very-low-birth-weight (VLBW, less than or equal to 1500 g) infants." | 1.28 | Symptomatic patent ductus arteriosus in very-low-birth-weight infants: 1987-1989. ( Mouzinho, AI; Risser, R; Rosenfeld, CR, 1991) |
| " for therapeutic reasons, the elimination kinetics appeared to follow a two-compartment open model, with a significant difference in the therminal plasma half-life between premature (26." | 1.26 | Pharmacokinetics of furosemide in neonates. ( Broquaire, M; Legagneur, M; Morselli, PL; Vert, P, 1982) |
| "Furosemide is an effective diuretic, the onset of pharmacologic action was within one hour, the peak action was sustained for three hours, and the duration of action was six hours." | 1.26 | The pharmacologic effects of furosemide therapy in the low-birth-weight infant. ( Oh, W; Pollak, A; Ross, BS, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (77.78) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 1 (3.70) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capozza, M | 1 |
| Chinellato, I | 1 |
| Guarnieri, V | 1 |
| Di Lorgi, N | 1 |
| Accadia, M | 1 |
| Traggiai, C | 1 |
| Mattioli, G | 1 |
| Di Mauro, A | 1 |
| Laforgia, N | 1 |
| Segar, JL | 1 |
| Borgia, F | 1 |
| De Pasquale, L | 1 |
| Cacace, C | 1 |
| Meo, P | 1 |
| Guarneri, C | 1 |
| Cannavo, SP | 1 |
| Kassner, EG | 1 |
| Tuck, S | 1 |
| Morselli, P | 1 |
| Broquaire, M | 2 |
| Vert, P | 2 |
| Zenk, KE | 1 |
| Legagneur, M | 1 |
| Morselli, PL | 1 |
| Oh, W | 2 |
| Guignard, JP | 2 |
| Dubourg, L | 1 |
| Gouyon, JB | 2 |
| Scales, JW | 1 |
| Krowchuk, DP | 1 |
| Schwartz, RP | 1 |
| Jorizzo, JL | 1 |
| Ross, BS | 1 |
| Pollak, A | 1 |
| Woo, WC | 1 |
| Dupont, C | 1 |
| Collinge, J | 1 |
| Aranda, JV | 3 |
| Cohen, S | 1 |
| Neims, AH | 1 |
| Cowan, RH | 1 |
| Waldo, AL | 1 |
| Harris, HB | 1 |
| Cassady, G | 1 |
| Brans, YW | 1 |
| Loggie, JM | 1 |
| Kleinman, LI | 1 |
| Van Maanen, EF | 1 |
| Mouzinho, AI | 1 |
| Rosenfeld, CR | 1 |
| Risser, R | 1 |
| Chemtob, S | 1 |
| Laudignon, N | 1 |
| Sasyniuk, BI | 1 |
| Ertl, T | 1 |
| Sulyok, E | 1 |
| Bódis, J | 1 |
| Csaba, IF | 1 |
| Nouaille, J | 1 |
| Solc, J | 1 |
| Knorr, D | 1 |
| Robertson, NR | 1 |
| Guerricchio, G | 1 |
| Van der Horst, RL | 1 |
| Richardson, H | 1 |
| Sacrez, R | 1 |
| Geisert, J | 1 |
| Willard, D | 1 |
| Plöchl, E | 1 |
| Stur, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease[NCT01721655] | Phase 2/Phase 3 | 40 participants (Anticipated) | Interventional | 2012-10-31 | Recruiting | ||
| A Retrospective Chart Review Evaluating the Impact of Steroid, Diuretic, and Fluid Use Practice Trends in Extreme Premature Infants at Risk for Bronchopulmonary Dysplasia (BPD) at a Single Center Neonatal Intensive Care Unit[NCT04971694] | 175 participants (Anticipated) | Observational | 2021-09-08 | Recruiting | |||
| Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis[NCT02469597] | Phase 2 | 46 participants (Actual) | Interventional | 2013-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT02469597)
Timeframe: Participants will be followed for the duration of hospital stay up to 1 week
| Intervention | Days (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | 3.1 |
| Placebo | 3.0 |
(NCT02469597)
Timeframe: 2 hours after medication adminstration
| Intervention | Percentage change in oxygen saturation (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -0.14 |
| Placebo | 0.2 |
(NCT02469597)
Timeframe: 4 hours after medication adminstration
| Intervention | Percentage change in oxygen saturation (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -0.19 |
| Placebo | 0.29 |
(NCT02469597)
Timeframe: Within 72 hours of medication administration
| Intervention | participants (Number) |
|---|---|
| Single Dose of Furosemide | 0 |
| Placebo | 0 |
(NCT02469597)
Timeframe: 2 hours after medication adminstration
| Intervention | Percentage change in respiratory rate (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -3.7 |
| Placebo | -1.7 |
(NCT02469597)
Timeframe: 4 hours after medication adminstration
| Intervention | Percentage change in respiratory rate (Least Squares Mean) |
|---|---|
| Single Dose of Furosemide | -2.8 |
| Placebo | -5.4 |
5 reviews available for furosemide and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
Topics: Bronchopulmonary Dysplasia; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Infant, Newbor | 2012 |
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
Topics: Bronchopulmonary Dysplasia; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Infant, Newbor | 2012 |
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
Topics: Bronchopulmonary Dysplasia; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Infant, Newbor | 2012 |
Neonatal diuretic therapy: furosemide, thiazides, and spironolactone.
Topics: Bronchopulmonary Dysplasia; Diuretics; Ductus Arteriosus, Patent; Furosemide; Humans; Infant, Newbor | 2012 |
An overview of perinatal clinical pharmacology.
Topics: Abnormalities, Drug-Induced; Analgesics; Bupivacaine; Carbamazepine; Chloramphenicol; Diazepam; Digo | 1981 |
[Diuretics in the neonatal period].
Topics: Benzothiadiazines; Bronchopulmonary Dysplasia; Diuretics; Furosemide; Heart Failure; Humans; Infant, | 1995 |
Adverse effects of drugs on the immature kidney.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Female; Fetus; Furosemide; Glome | 1988 |
Furosemide and vitamin E. Two problem drugs in neonatology.
Topics: Acid-Base Imbalance; Anemia; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Diuresis; Ductus Arter | 1986 |
22 other studies available for furosemide and Infant, Newborn, Diseases
| Article | Year |
|---|---|
Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
Topics: Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Clodronic Acid; Diphosphonates; F | 2018 |
Subcutaneous fat necrosis of the newborn: be aware of hypercalcaemia.
Topics: Asphyxia Neonatorum; Fat Necrosis; Female; Furosemide; Humans; Hypercalcemia; Infant, Newborn; Infan | 2006 |
New drugs, more complications--old drugs, new complications: drug-related sequelae of neonatal intensive care.
Topics: Bezoars; Critical Care; Drug-Related Side Effects and Adverse Reactions; Furosemide; Humans; Hyperte | 1984 |
Plasma and urinary kinetics of furosemide in newborn infants.
Topics: Furosemide; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Water-Electroly | 1983 |
Pharmacokinetics of furosemide in neonates.
Topics: Female; Furosemide; Gestational Age; Half-Life; Humans; Infant, Newborn; Infant, Newborn, Diseases; | 1982 |
Renal functions and clinical disorders in the neonate.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Asphyxia Neonatorum; Furosemide; Humans; Indomethacin; I | 1981 |
An infant with firm, fixed plaques.
Topics: Failure to Thrive; Fat Necrosis; Female; Fluid Therapy; Furosemide; Glucocorticoids; Humans; Hyperca | 1998 |
The pharmacologic effects of furosemide therapy in the low-birth-weight infant.
Topics: Furosemide; Heart Failure; Humans; Hydrogen-Ion Concentration; Infant; Infant, Low Birth Weight; Inf | 1978 |
Effects of furosemide in the newborn.
Topics: Body Water; Chlorides; Diuresis; Electrolytes; Furosemide; Humans; Infant; Infant, Newborn; Infant, | 1978 |
Drug utilization in a newborn intensive care unit.
Topics: Ampicillin; Bicarbonates; Birth Weight; Canada; Chloramphenicol; Drug Therapy, Combination; Drug Uti | 1976 |
Neonatal paroxysmal supraventricular tachycardia with hydrops.
Topics: Digoxin; Edema; Electrocardiography; Female; Fetal Diseases; Furosemide; Heart Ventricles; Humans; I | 1975 |
Renal function and diuretic therapy in infants and children. Part III.
Topics: Adolescent; Calcium; Child; Child, Preschool; Diuresis; Diuretics; Edema; Ethacrynic Acid; Female; F | 1975 |
Symptomatic patent ductus arteriosus in very-low-birth-weight infants: 1987-1989.
Topics: Analysis of Variance; Cardiac Surgical Procedures; Colloids; Ductus Arteriosus, Patent; Female; Flui | 1991 |
Plasma prolactin levels in full-term newborn infants with idiopathic edema: response to furosemide.
Topics: Diuresis; Edema; Furosemide; Humans; Infant, Newborn; Infant, Newborn, Diseases; Potassium; Prolacti | 1986 |
[Medical treatment of heart failure in infants and young children].
Topics: Anti-Bacterial Agents; Anticoagulants; Aortic Coarctation; Bradycardia; Chlorothiazide; Diet, Sodium | 1969 |
[Investigation on tetrahydroaldosterone excretion in childhood using gas chromatography with an electron capture detector].
Topics: Addison Disease; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Age Factors; Aldosterone; Ang | 1972 |
Prolonged continuous positive airways pressure for pulmonary oedema due to persistent ductus arteriosus in the newborn.
Topics: Carbon Dioxide; Cardiac Catheterization; Ductus Arteriosus, Patent; Female; Furosemide; Humans; Infa | 1974 |
[Wolff-Parkinson-White syndrome and paroxysmal tachycardia in infants. (Apropos of a case)].
Topics: Ajmaline; Digoxin; Electrocardiography; Furosemide; Humans; Infant, Newborn; Infant, Newborn, Diseas | 1972 |
Congenital atrial flutter and cardiac failure presenting as hydrops foetalis at birth.
Topics: Atrial Flutter; Birth Weight; Body Weight; Digoxin; Edema; Electrocardiography; Female; Fetal Diseas | 1970 |
Frusemide in heart failure of infancy.
Topics: Administration, Oral; Aortic Coarctation; Body Weight; Chlorides; Ductus Arteriosus, Patent; Female; | 1971 |
[Place of new diuretics in the treatment of some neonatal diseases].
Topics: Brain Edema; Diuresis; Edema; Ethacrynic Acid; Furosemide; Humans; Infant, Newborn; Infant, Newborn, | 1969 |
[Sweat studies in renal diabetes insipidus during treatment with saluretics].
Topics: Chlorides; Chlorthalidone; Diabetes Insipidus; Diuretics; Furosemide; Humans; Infant, Newborn; Infan | 1965 |